David P. Steensma

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

David P. Steensma, Rafael Bejar, Siddhartha Jaiswal et al. · Blood · 2015 · 1.9K citations · Full text

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

Animesh Pardanani, Ross L. Levine, Terra L. Lasho et al. · Blood · 2006 · 1K citations · Full text

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola et al. · Blood · 2014 · 960 citations · Full text

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

Rafael Bejar, Allegra M. Lord, Kristen E. Stevenson et al. · Blood · 2014 · 543 citations · Full text

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes

David P. Steensma, Gordon W. Dewald, Terra L. Lasho et al. · Blood · 2005 · 466 citations · Full text